New drugs target root cause of mastocytosis
Featured

New drugs target root cause of mastocytosis

Child Vaccines

UCSF Study Links Autoantibodies to Preterm Birth Risk
Child Vaccines
October 14, 2026

UCSF Study Links Autoantibodies to Preterm Birth Risk

A UCSF study links autoantibodies to preterm birth risk, identifying antibodies that may trigger early...

Immune Cell Ratio Predicts Healthy Aging, Disease Risks
Child Vaccines
October 10, 2026

Immune Cell Ratio Predicts Healthy Aging, Disease Risks

The immune cell ratio predicts healthy aging and disease risks, offering insights into personalized health...

Gene signatures reveal severe COVID risk in children
Child Vaccines
October 7, 2026

Gene signatures reveal severe COVID risk in children

New research identifies gene signatures linked to severe COVID-19 in children, offering insights into respiratory...

Germ Control

Read our latest Germ Control articles.

New treatments for myelofibrosis and anemia emerge
Germ Control October 23, 2026

New treatments for myelofibrosis and anemia emerge

New treatments for myelofibrosis and anemia may improve symptoms and quality of life for patients.

US hospitals top global oncology rankings
Germ Control October 22, 2026

US hospitals top global oncology rankings

US hospitals rank high in global oncology rankings, with Memorial Sloan Kettering in first place,...

Growth Charts

Lunch Nutrition

All Posts

New drugs target root cause of mastocytosis
Lunch Nutrition

New drugs target root cause of mastocytosis

New drugs target root cause of mastocytosis, offering hope for patients with systemic mastocytosis.

Black Americans face double multiple myeloma risk, experts say
School Illness

Black Americans face double multiple myeloma risk, experts say

Black Americans face double multiple myeloma risk, experts say. Explore the disparity in incidence and treatment challenges.

Patients with polycythemia vera continue experiencing symptoms
Lunch Nutrition

Patients with polycythemia vera continue experiencing symptoms

Patients with polycythemia vera continue experiencing symptoms despite treatment, impacting daily life. Learn why symptoms persist and management strategies.

FDA Approves Jaypirca for Untreated CLL and SLL
Germ Control

FDA Approves Jaypirca for Untreated CLL and SLL

The FDA approves Jaypirca for previously untreated CLL and SLL without del(17p), showing improved outcomes in a major clinical trial.

New treatments for myelofibrosis and anemia emerge
Germ Control

New treatments for myelofibrosis and anemia emerge

New treatments for myelofibrosis and anemia may improve symptoms and quality of life for patients.

US hospitals top global oncology rankings
Germ Control

US hospitals top global oncology rankings

US hospitals rank high in global oncology rankings, with Memorial Sloan Kettering in first place, one of the top oncology...

New dual-imaging catheter assesses heart attack risk in humans
Germ Control

New dual-imaging catheter assesses heart attack risk in humans

New dual-imaging catheter assesses heart attack risk by detecting plaque buildup in arteries, potentially improving cardiovascular disease understanding.

Risk-taking predicts heavier drinking before it worsens
Growth Charts

Risk-taking predicts heavier drinking before it worsens

New research reveals risk-taking behavior predicts heavier drinking before alcohol use disorder worsens, overturning long-held assumptions about its causes.

Сапфировые брекеты для детей и подростков: незаметный путь к идеальной улыбке
Growth Charts

Сапфировые брекеты для детей и подростков: незаметный путь к идеальной улыбке

Формирование красивой улыбки и правильного прикуса в детском и подростковом возрасте — важная задача ортодонтического лечения. Однако многие дети и...

Marginalized patients die sooner from metastatic breast cancer
Lunch Nutrition

Marginalized patients die sooner from metastatic breast cancer

People who are marginalized or lack access to a primary care provider face a higher risk of early death from...

Show More →